315 related articles for article (PubMed ID: 38685115)
1. Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions.
Chen J; Ma B; Yang Y; Wang B; Hao J; Zhou X
Biomark Res; 2024 Apr; 12(1):45. PubMed ID: 38685115
[TBL] [Abstract][Full Text] [Related]
2. Disulfidptosis: A new type of cell death.
Xiao F; Li HL; Yang B; Che H; Xu F; Li G; Zhou CH; Wang S
Apoptosis; 2024 Jun; ():. PubMed ID: 38886311
[TBL] [Abstract][Full Text] [Related]
3. In what area of biology has a "new" type of cell death been discovered?
Wang X; Lin J; Li Z; Wang M
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188955. PubMed ID: 37451411
[TBL] [Abstract][Full Text] [Related]
4. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis.
Liu X; Nie L; Zhang Y; Yan Y; Wang C; Colic M; Olszewski K; Horbath A; Chen X; Lei G; Mao C; Wu S; Zhuang L; Poyurovsky MV; James You M; Hart T; Billadeau DD; Chen J; Gan B
Nat Cell Biol; 2023 Mar; 25(3):404-414. PubMed ID: 36747082
[TBL] [Abstract][Full Text] [Related]
5. Disulfidptosis: disulfide stress-induced cell death.
Liu X; Zhuang L; Gan B
Trends Cell Biol; 2024 Apr; 34(4):327-337. PubMed ID: 37574347
[TBL] [Abstract][Full Text] [Related]
6. Disulfidptosis: Six Riddles Necessitating Solutions.
Wang X; Zheng C; Yao H; Guo Y; Wang Y; He G; Fu S; Deng X
Int J Biol Sci; 2024; 20(3):1042-1044. PubMed ID: 38322120
[TBL] [Abstract][Full Text] [Related]
7. Disulfidptosis, A Novel Cell Death Pathway: Molecular Landscape and Therapeutic Implications.
Gu Q; An Y; Xu M; Huang X; Chen X; Li X; Shan H; Zhang M
Aging Dis; 2024 May; ():. PubMed ID: 38739940
[TBL] [Abstract][Full Text] [Related]
8.
Sun XY; Xiao M; Fu M; Gao Q; Li RF; Wang J; Li SL; Ge XY
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540687
[TBL] [Abstract][Full Text] [Related]
9. NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation.
Liu X; Zhang Y; Zhuang L; Olszewski K; Gan B
Genes Dis; 2021 Nov; 8(6):731-745. PubMed ID: 34522704
[TBL] [Abstract][Full Text] [Related]
10. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients.
Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324
[TBL] [Abstract][Full Text] [Related]
11. NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors.
Zhong Z; Zhang C; Ni S; Ma M; Zhang X; Sang W; Lv T; Qian Z; Yi C; Yu B
Redox Biol; 2023 Jul; 63():102711. PubMed ID: 37148740
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer genetic analysis of disulfidptosis-related gene set.
Liu H; Tang T
Cancer Genet; 2023 Nov; 278-279():91-103. PubMed ID: 37879141
[TBL] [Abstract][Full Text] [Related]
13. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer.
Liu X; Olszewski K; Zhang Y; Lim EW; Shi J; Zhang X; Zhang J; Lee H; Koppula P; Lei G; Zhuang L; You MJ; Fang B; Li W; Metallo CM; Poyurovsky MV; Gan B
Nat Cell Biol; 2020 Apr; 22(4):476-486. PubMed ID: 32231310
[TBL] [Abstract][Full Text] [Related]
14. Molecular subtypes of disulfidptosis-regulated genes and prognosis models for predicting prognosis, tumor microenvironment infiltration, and therapeutic response in hepatocellular carcinoma.
Qu J; Guan H; Zheng Q; Sun F
Int J Biol Macromol; 2024 Mar; 261(Pt 1):129584. PubMed ID: 38246443
[TBL] [Abstract][Full Text] [Related]
15. Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma.
Zhou Y; Cao Y; Liu W; Wang L; Kuang Y; Zhou Y; Chen Q; Cheng Z; Huang H; Zhang W; Jiang X; Wang B; Ren C
Front Immunol; 2023; 14():1294459. PubMed ID: 38162649
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer.
Li J; Yu T; Sun J; Ma M; Zheng Z; He Y; Kang W; Ye X
Cancer Cell Int; 2024 Mar; 24(1):112. PubMed ID: 38528532
[TBL] [Abstract][Full Text] [Related]
17. Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy.
Zhao D; Meng Y; Dian Y; Zhou Q; Sun Y; Le J; Zeng F; Chen X; He Y; Deng G
Redox Biol; 2023 Dec; 68():102966. PubMed ID: 38035663
[TBL] [Abstract][Full Text] [Related]
18. Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer.
Jin T; Yin T; Xu R; Liu H; Yuan S; Xue Y; Zhang J; Wang H
Transl Oncol; 2024 Jun; 44():101938. PubMed ID: 38492499
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer and single-cell analysis of actin cytoskeleton genes related to disulfidptosis.
Shen LP; Jiang HT
Open Med (Wars); 2024; 19(1):20240929. PubMed ID: 38584831
[TBL] [Abstract][Full Text] [Related]
20. The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-associated genes in lung adenocarcinoma.
Qi C; Ma J; Sun J; Wu X; Ding J
Aging (Albany NY); 2023 Jun; 15(11):5075-5095. PubMed ID: 37315289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
